Gilead Sciences (GILD) revenue

Revenue · fiscal 2025
$29.44B

Gilead Sciences (GILD) reported revenue of $29.44B in fiscal 2025 (the year ended December 31, 2025). That is 2.4% higher than the $28.75B of fiscal 2024. Figures as of 18 Nov 2026, 12:17 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$29.44B
Change on fiscal 2024
+2.4%
Growth, 5 years
+3.6% a year
Growth, 10 years
−1.0% a year
Highest on record
$32.64Bfiscal 2015
Lowest on record
$4.23Bfiscal 2007
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Gilead Sciences revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 3.6% a year; over ten years the rate was −1.0% a year. Across the 19 fiscal years on record (2007–2025), the highest was $32.64B in fiscal 2015 and the lowest $4.23B in fiscal 2007.

History · 19 fiscal years

Revenue by fiscal year

Gilead Sciences revenue, year by year

Gilead Sciences (GILD) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$29.44B 2.4% up
2024$28.75B 6.0% up
2023$27.12B 0.6% down
2022$27.28B 0.1% down
2021$27.31B 10.6% up
2020$24.69B 10.0% up
2019$22.45B 1.5% up
2018$22.13B 15.2% down
2017$26.11B 14.1% down
2016$30.39B 6.9% down
2015$32.64B 31.1% up
2014$24.89B 122.2% up
2013$11.20B 15.5% up
2012$9.70B 15.7% up
2011$8.39B 5.5% up
2010$7.95B 13.4% up
2009$7.01B 31.4% up
2008$5.34B 26.1% up
2007$4.23B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Gilead Sciences and comparable companies
CompanyRevenueFiscal year
Thermo Fisher Scientific TMO$44.56B2025
Amgen AMGN$36.75B2025
Gilead Sciences GILD$29.44B2025
Abbott Laboratories ABT$44.33B2025
Novo Nordisk NVODKK 309.06B2025
Pfizer PFE$62.58B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GILD

Gilead Sciences, figure by figure

Gilead Sciences (GILD) overview: price, valuation and scorecardAll health care companies by market value

Gilead Sciences revenue: questions and answers

What is Gilead Sciences's revenue?

Gilead Sciences (GILD) reported revenue of $29.44B in fiscal 2025 (the year ended December 31, 2025). That is 2.4% higher than the $28.75B of fiscal 2024.

What is the growth rate of Gilead Sciences's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 3.6% a year; over ten years the rate was −1.0% a year.

What are the highest and lowest revenue figures on record for Gilead Sciences?

Across the 19 fiscal years on record (2007–2025), the highest was $32.64B in fiscal 2015 and the lowest $4.23B in fiscal 2007.

How is Gilead Sciences's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Gilead Sciences it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Gilead Sciences (GILD) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/GILD/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.